M&A Deal Summary

Elekta Acquires Resonant Medical

On May 31, 2010, Elekta acquired medical products company Resonant Medical for 30M CAD

Acquisition Highlights
  • This is Elekta’s 2nd transaction in the Medical Products sector.
  • This is Elekta’s 3rd largest (disclosed) transaction.
  • This is Elekta’s 1st transaction in Canada.
  • This is Elekta’s 1st transaction in Quebec.

M&A Deal Summary

Date 2010-05-31
Target Resonant Medical
Sector Medical Products
Buyer(s) Elekta
Deal Type Add-on Acquisition
Deal Value 30M CAD

Target

Resonant Medical

Montreal, Quebec, Canada
Resonant Medical, Inc. is a developer of revolutionary clinical solutions that are safe and gentle for the patient while increasing the accuracy and precision of radiotherapy cancer care.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Elekta

Stockholm, Sweden

Category Company
Founded 1972
Sector Medical Products
Employees4,536
Revenue 18.0B SEK (2025)
DESCRIPTION

Elekta is an international medical-technology Group, providing highly advanced clinical solutions for high precision radiation treatment of cancer and for non- or minimally invasive treatment of brain disorders. Clinical solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy for image-guided radiation therapy (IGRT) as well as associated software systems. Elekta was founded in 1972 and is based in Stockholm, Sweden.


DEAL STATS #
Overall 5 of 9
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 5 of 9
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 2
Year: 2010 M&A 1 of 1
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-08 CMS

St. Louis, Missouri, United States

CMS, Inc. is a provider in the development and support of radiation treatment planning and workflow management solutions.

Buy $75M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-15 Nucletron B.V.

Veenendaal, Netherlands

Nucletron B.V. is a provider in brachytherapy treatment planning and delivery.

Buy €365M